
Keywords: 5-ASA; 5-aminosalicylates; IMID; immune-mediated inflammatory diseases; IPNIC; International Program to develop New Indexes in Crohn's disease; mAb; monoclonal antibody; Crohn's disease; Ulcerative colitis; Disease monitoring; Healthcare delivery; Individ